{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:34:29Z","timestamp":1770885269002,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The predictors of recurrent autoimmune hepatitis (R-AIH) after liver transplantation (LT) are heterogeneous with limited data to guide immunosuppression, with little data on impact of race.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aims.<\/jats:title>\n            <jats:p>To describe the incidence, predictors, and outcomes of R-AIH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We studied patients undergoing LT for AIH during 2000\u20132017 at our center. Liver biopsies were performed for clinical indications. R-AIH was defined using clinical and histologic criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Among 75 patients undergoing LT for AIH (mean age 45\u2009\u00b1\u200916, 65% female individuals, 19% Black), 71 (95%) received antithymocyte globulin induction with tacrolimus-based immunosuppression. R-AIH developed in 20 (27%) patients at a median interval of 313 d (interquartile range, 155\u20131205). R-AIH was associated with level 2 HLA-DR mismatch (hazard ratio, 3.6; (95% confidence interval, 1.3-9.9; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.01) and Black race (hazard ratio, 4.5; 95% confidence interval, 1.8-11.8; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.002)] in the multivariable analysis. R-AIH developed in 62% of patients with level 2 HLA-DR mismatch on single-agent immunosuppression but in &lt;20% of patients with no or 1 HLA-DR mismatch regardless of maintenance immunosuppression. R-AIH developed in 8 (57%) of 14 Black patients (71% on single-agent and 43% on dual-agent maintenance immunosuppression). Patient and graft survival were not impacted by R-AIH over a median follow-up of 8.3 y (interquartile range, 3\u201312).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>High-level HLA-DR mismatch and Black recipient race are associated with an increased risk of R-AIH. Immunosuppression did not predict R-AIH, but higher rates of disease recurrence with single-agent maintenance immunosuppression with these risk factors were observed and may guide maintenance immunosuppression in LT for AIH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001160","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T18:01:16Z","timestamp":1623348076000},"page":"e714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation"],"prefix":"10.1097","volume":"7","author":[{"given":"Marshall","family":"McCabe","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rush","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Lammert","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavish R.","family":"Patidar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Nephew","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romil","family":"Saxena","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcin","family":"Ekser","sequence":"additional","affiliation":[{"name":"Department of Transplant Surgery, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Salven","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashekhar","family":"Kubal","sequence":"additional","affiliation":[{"name":"Department of Transplant Surgery, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan","family":"Ghabril","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cld.2016.12.010","article-title":"Autoimmune hepatitis in the liver transplant graft.","volume":"21","author":"Beal","year":"2017","journal-title":"Clin Liver Dis"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review.","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation.","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease.","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/lt.23381","article-title":"Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.","volume":"18","author":"Mangus","year":"2012","journal-title":"Liver Transpl"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document.","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel.","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection.","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study.","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"R10-20240805","first-page":"44","article-title":"[Autoimmune hepatitis recurrence after liver transplantation: 15 years experience in Peru].","volume":"38","author":"C\u00e1rdenas Ram\u00edrez","year":"2018","journal-title":"Rev Gastroenterol Peru"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1746.2012.07125.x","article-title":"Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients.","volume":"28","author":"Dbouk","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.","volume":"52","author":"Duclos-Vall\u00e9e","year":"2003","journal-title":"Gut"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation.","volume":"7","author":"Gonz\u00e1lez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0041-1345(02)03570-4","article-title":"Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning.","volume":"34","author":"Heffron","year":"2002","journal-title":"Transplant Proc"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients.","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation.","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"},{"issue":"Pt 1","key":"R17-20240805","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis.","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis.","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1440-1746.2002.02632.x","article-title":"Disease recurrence after liver transplantation in Western Australia.","volume":"17","author":"Yusoff","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0041-1345(99)00227-4","article-title":"Liver transplantation for autoimmune hepatitis: rejection and recurrence.","volume":"31","author":"Narumi","year":"1999","journal-title":"Transplant Proc"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease.","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation.","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation.","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"e12936","DOI":"10.1111\/ctr.12936","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis.","volume":"31","author":"Puustinen","year":"2017","journal-title":"Clin Transplant"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00268-001-0213-2","article-title":"Liver transplantation for nonviral, nonmalignant diseases: problem of recurrence.","volume":"26","author":"Renz","year":"2002","journal-title":"World J Surg"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis.","volume":"46","author":"Verma","year":"2007","journal-title":"Hepatology"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2018.11.028","article-title":"Association between Black race and presentation and liver-related outcomes of patients with autoimmune hepatitis.","volume":"17","author":"de Boer","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.mayocp.2018.04.025","article-title":"Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients.","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin Proc"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:10:38Z","timestamp":1722834638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001160","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]}}}